Tennessee Oncology, PLLC - Dalton

Clinical research site in Dalton, Georgia · 1504 N THORNTON AVE STE 102, DALTON, GA 30720-8394 · (706) 226-0508

Part of Tennessee Oncology

As of July 2026, 2 paid clinical trials are recruiting at Tennessee Oncology, PLLC - Dalton in Dalton, Georgia. Active studies at this site cover conditions such as Cancer of the Prostate, Hormone Sensitive Prostate Cancer and Metastatic Castration Sensitive Prostate Cancer (mCSPC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Tennessee Oncology, PLLC - Dalton (2)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

133 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

More research sites in Dalton

Nephrology & Hypertension Specialists (2 trials)
89bio Clinical Study Site (1 trial)
Ctr for Spine and Pain Medicine (1 trial)
GA Interventional Pain-G, LLC (1 trial)
Hamilton Amb Surg Ctr (1 trial)
Hamilton Med Ctr (1 trial)
Hamilton Medical Center (1 trial)
Hamilton Medical Center - Peeples Cancer Institute (1 trial)
Ipc Dalton Asc (1 trial)
Southeast Clinical Research Center (1 trial)

Explore more

Paid clinical trials in Dalton, GA · Georgia clinical trials